Aneuploidy is highly detrimental during development yet common in cancers and pathogenic fungi - what gives rise to differences in aneuploidy tolerance remains unclear. We previously showed that wild isolates of tolerate chromosome amplification while laboratory strains used as a model for aneuploid syndromes do not. Here, we mapped the genetic basis to Ssd1, an RNA-binding translational regulator that is functional in wild aneuploids but defective in laboratory strain W303. Loss of recapitulates myriad aneuploidy signatures previously taken as eukaryotic responses. We show that aneuploidy tolerance is enabled via a role for Ssd1 in mitochondrial physiology, including binding and regulating nuclear-encoded mitochondrial mRNAs, coupled with a role in mitigating proteostasis stress. Recapitulating defects with combinatorial drug treatment selectively blocked proliferation of wild-type aneuploids compared to euploids. Our work adds to elegant studies in the sensitized laboratory strain to present a mechanistic understanding of eukaryotic aneuploidy tolerance.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970514PMC
http://dx.doi.org/10.7554/eLife.52063DOI Listing

Publication Analysis

Top Keywords

aneuploidy tolerance
16
genetic basis
8
laboratory strain
8
aneuploidy
6
basis aneuploidy
4
tolerance
4
tolerance wild
4
wild yeast
4
yeast aneuploidy
4
aneuploidy highly
4

Similar Publications

The role of gene copy number variation in antimicrobial resistance in human fungal pathogens.

NPJ Antimicrob Resist

January 2025

Département de Biochimie, de Microbiologie et de Bio-informatique, Faculté des Sciences et de Génie, Université Laval, Québec City, G1V 0A6 Canada.

Faced with the burden of increasing resistance to antifungals in many fungal pathogens and the constant emergence of new drug-resistant strains, it is essential to assess the importance of various resistance mechanisms. Fungi have relatively plastic genomes and can tolerate genomic copy number variation (CNV) caused by aneuploidy and gene amplification or deletion. In many cases, these genomic changes lead to adaptation to stressful conditions, including those caused by antifungal drugs.

View Article and Find Full Text PDF

Rho(D) immune globulin shortage and fetal Rh(D) screening with cell-free DNA.

Curr Opin Obstet Gynecol

December 2024

University of North Carolina School of Medicine, Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, Chapel Hill, North Carolina, USA.

Purpose Of Review: Despite the availability of Rh(D) immune globulin (RhIg) to prevent alloimmunization in Rh(D)-negative pregnant patients, anti-Rh(D) alloimmunization remains a prevalent cause of hemolytic disease of the fetus and newborn (HDFN). Recent RhIg shortages have caused clinicians and professional societies to identify methods to prioritize RhIg administration. New cell-free DNA (cfDNA) tests to predict fetal red blood cell antigen genotypes have been proposed as an option to prioritize the administration of RhIg to Rh(D)-negative pregnant people.

View Article and Find Full Text PDF

This study explored the genomic alterations in , a key yeast in industrial biotechnology, under both spontaneous and mutagen-induced conditions. Our findings reveal that spontaneous mutations occur at a rate of approximately 4 × 10 events per base pair per cell division, primarily manifesting as single-nucleotide variations (SNVs) and small insertions and deletions (InDels). Notably, C-to-T/G-to-A transitions and C-to-A/G-to-T transversions dominate the spontaneous SNVs, while 1 bp deletions, likely resulting from template slippage, are the most frequent InDels.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to evaluate the anti-cancer effects of a drug called compound-9, which inhibits a protein known as MPS1/TTK, in gastric cancer cell lines.
  • - Through various assays like cell viability, apoptosis, and protein analysis, the researchers found that sensitivity to the inhibitor varied among different genetic profiles of gastric cancer, particularly noting differences between TP53 mutated and wild-type cell lines.
  • - The findings suggest that compound-9 could be a promising targeted therapy for gastric cancer, especially in cell lines with certain genetic characteristics, by leading to quicker cell death in TP53 wild-type cells compared to mutated ones.
View Article and Find Full Text PDF

About 70% of human cleavage stage embryos show chromosomal mosaicism, falling to 20% in blastocysts. Chromosomally mosaic human blastocysts can implant and lead to healthy new-borns with normal karyotypes. Studies in mouse embryos and human gastruloids showed that aneuploid cells are eliminated from the epiblast by p53-mediated apoptosis while being tolerated in the trophectoderm.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!